|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou J, Jin B, Jin Y, Liu Y and Pan J: The
antihelminthic drug niclosamide effectively inhibits the malignant
phenotypes of uveal melanoma in vitro and in vivo. Theranostics.
7:1447–1462. 2017. View Article : Google Scholar :
|
|
3
|
Rozeman EA, Dekker TJA, Haanen J and Blank
CU: Advanced melanoma: Current treatment options, biomarkers, and
future perspectives. Am J Clin Dermatol. 19:303–317. 2018.
View Article : Google Scholar
|
|
4
|
Guo W, Wang H, Yang Y, Guo S, Zhang W, Liu
Y, Yi X, Ma J, Zhao T, Liu L, et al: Down-regulated miR-23a
contributes to the metastasis of cutaneous melanoma by promoting
autophagy. Theranostics. 7:2231–2249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Y: The novel regulatory role of
lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med.
22:5768–5775. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu B and Wang S: Angio-LncRs: LncRNAs that
regulate angio-genesis and vascular disease. Theranostics.
8:3654–3675. 2018. View Article : Google Scholar :
|
|
7
|
Krause HM: New and prospective roles for
lncRNAS in organelle formation and function. Trends Genet.
34:736–745. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balas SM and Johnson AM: Exploring the
mechanisms behind long noncoding RNAs and cancer. Noncoding RNA
Res. 3:108–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anastasiadou E, Faggioni A, Trivedi P and
Slack FJ: The nefarious nexus of noncoding RNAs in cancer. Int J
Mol Sci. 19:pii. E20722018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu X, Zheng H, Tse G, Zhang L and Wu WKK:
CASC2: An emerging tumour-suppressing long noncoding RNA in human
cancers and melanoma. Cell Prolif. 51:e125062018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu X, Zheng H, Tse G, Chan MT and Wu WK:
Long non-coding RNAs in melanoma. Cell Prolif. 51:e124572018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Richtig G, Ehall B, Richtig E,
Aigelsreiter A, Gutschner T and Pichler M: Function and clinical
implications of long non-coding RNAs in melanoma. Int J Mol Sci.
18:pii. E7152017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsumoto A, Pasut A, Matsumoto M,
Yamashita R, Fung J, Monteleone E, Saghatelian A, Nakayama KI,
Clohessy JG and Pandolfi PP: mTORC1 and muscle regeneration are
regulated by the LINC00961-encoded SPAR polypeptide. Nature.
541:228–232. 2017. View Article : Google Scholar
|
|
15
|
Tajbakhsh S: lncRNA-encoded polypeptide
SPAR(s) with mTORC1 to regulate skeletal muscle regeneration. Cell
Stem Cell. 20:428–430. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu XW, Xu N, Zheng YG, Li QX and Shi JS:
Increased expression of long noncoding RNA LINC00961 suppresses
glioma metastasis and correlates with favorable prognosis. Eur Rev
Med Pharmacol Sci. 22:4917–4924. 2018.PubMed/NCBI
|
|
17
|
Huang Z, Lei W, Tan J and Hu HB: Long
noncoding RNA LINC00961 inhibits cell proliferation and induces
cell apoptosis in human non-small cell lung cancer. J Cell Biochem.
119:9072–9080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kunz M, Löffler-Wirth H, Dannemann M,
Willscher E, Doose G, Kelso J, Kottek T, Nickel B, Hopp L,
Landsberg J, et al: RNA-seq analysis identifies different
transcriptomic types and developmental trajectories of primary
melanomas. Oncogene. 37:6136–6151. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mou K, Liu B, Ding M, Mu X, Han D, Zhou Y
and Wang LJ: lncRNA-ATB functions as a competing endogenous RNA to
promote YAP1 by sponging miR-590-5p in malignant melanoma. Int J
Oncol. 53:1094–1104. 2018.PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Long J, Luo J and Yin X: miR-367 enhances
the proliferation and invasion of cutaneous malignant melanoma by
regulating phosphatase and tensin homolog expression. Mol Med Rep.
17:6526–6532. 2018.PubMed/NCBI
|
|
22
|
Ling JW, Lu PR, Zhang YB, Jiang S and
Zhang ZC: miR-367 promotes uveal melanoma cell proliferation and
migration by regulating PTEN. Genet Mol Res. 16:gmr160390672017.
View Article : Google Scholar
|
|
23
|
Liu XF, Hao JL, Xie T, Pant OP, Lu CB, Lu
CW and Zhou DD: The BRAF activated non-coding RNA: A pivotal long
non-coding RNA in human malignancies. Cell Prolif. 51:e124492018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rion N and Rüegg MA: LncRNA-encoded
peptides: More than translational noise? Cell Res. 27:604–605.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang B, Liu J, Zhang YH, Shen D, Liu S,
Lin F, Su J, Lin QF, Yan S, Li Y, et al: Long noncoding RNA
LINC00961 inhibits cell invasion and metastasis in human non-small
cell lung cancer. Biomed Pharmacother. 97:1311–1318. 2018.
View Article : Google Scholar
|
|
26
|
Chen WJ, Tang RX, He RQ, Li DY, Liang L,
Zeng JH, Hu XH, Ma J, Li SK and Chen G: Clinical roles of the
aberrantly expressed lncRNAs in lung squamous cell carcinoma: A
study based on RNA-sequencing and microarray data mining.
Oncotarget. 8:61282–61304. 2017.PubMed/NCBI
|
|
27
|
Chen D, Zhu M, Su H, Chen J, Xu X and Cao
C: LINC00961 restrains cancer progression via modulating
epithelial-mesenchymal transition in renal cell carcinoma. J Cell
Physiol. 234:7257–7265. 2019. View Article : Google Scholar
|
|
28
|
Li LJ, Zhao W, Tao SS, Leng RX, Fan YG,
Pan HF and Ye DQ: Competitive endogenous RNA network: Potential
implication for systemic lupus erythematosus. Expert Opin Ther
Targets. 21:639–648. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bossi L and Figueroa-Bossi N: Competing
endogenous RNAs: A target-centric view of small RNA regulation in
bacteria. Nat Rev Microbiol. 14:775–784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai Y and Wan J: Competing endogenous RNA
regulations in neurodegenerative disorders: Current challenges and
emerging insights. Front Mol Neurosci. 11:3702018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang C, Wu D, Gao L, Liu X, Jin Y, Wang D,
Wang T and Li X: Competing endogenous RNA networks in human cancer:
Hypothesis, validation, and perspectives. Oncotarget.
7:13479–13490. 2016.PubMed/NCBI
|
|
32
|
Qu J, Li M, Zhong W and Hu C: Competing
endogenous RNA in cancer: A new pattern of gene expression
regulation. Int J Clin Exp Med. 8:17110–17116. 2015.
|
|
33
|
Guo LL, Song CH, Wang P, Dai LP, Zhang JY
and Wang KJ: Competing endogenous RNA networks and gastric cancer.
World J Gastroenterol. 21:11680–11687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sarkar D, Leung EY, Baguley BC, Finlay GJ
and Askarian-Amiri ME: Epigenetic regulation in human melanoma:
Past and future. Epigenetics. 10:103–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Luan W, Li R, Liu L, Ni X, Shi Y, Xia Y,
Wang J, Lu F and Xu B: Long non-coding RNA HOTAIR acts as a
competing endogenous RNA to promote malignant melanoma progression
by sponging miR-152-3p. Oncotarget. 8:85401–85414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiao G, Zhang B, Meng J, Wang J, Xu C,
Tang SC, Li X, Zhang J, Liang R, Ren H and Sun X: miR-367
stimulates Wnt cascade activation through degrading FBXW7 in NSCLC
stem cells. Cell Cycle. 16:2374–2385. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui
R and Wang Y: High miR-196a and low miR-367 cooperatively correlate
with unfavorable prognosis of high-grade glioma. Int J Clin Exp
Pathol. 8:6576–6588. 2015.PubMed/NCBI
|
